Lyra Therapeutics, Inc.(LYRA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | Cavalier Jason Chief Financial Officer | Sale | -769 | -0.41%185,809 | $3.36 | $2,587 | View SEC filing | |
| 2026-01-08 | Palasis Maria President & CEO | Sale | -1,702 | -0.25%672,962 | $3.36 | $5,726 | View SEC filing | |
| 2025-11-13 | EDELMAN JOSEPH 10% Owner | Sale | -45,875 | -91.56%14,026 | $3.98 | $182,515 | View SEC filing | |
| 2025-11-10 | EDELMAN JOSEPH 10% Owner | Sale | -70,390 | -91.87%18,659 | $4.89 | $344,219 | View SEC filing | |
| 2025-07-14 | Palasis Maria President & CEO | Sale | -1,565 | -0.23%674,664 | $8.91 | $13,944 | View SEC filing | |
| 2025-07-14 | Cavalier Jason Chief Financial Officer | Sale | -684 | -0.37%186,578 | $8.91 | $6,094 | View SEC filing | |
| 2023-11-13 | Waksal Harlan Executive Chair | Purchase | +25,000 | +10.55%261,966 | $2.96 | $74,095 | View SEC filing | |
| 2023-06-02 | EDELMAN JOSEPH Director, 10% Owner | Purchase | +5,416,248 | +68.92%13,274,533 | $1.66 | $8,999,999 | View SEC filing | |
| 2023-06-02 | NORTH BRIDGE VENTURE PARTNERS V-B LP 10% Owner | Purchase | +2,708,124 | +68.35%3,123,551 | $1.66 | $4,499,999 | View SEC filing | |
| 2023-06-02 | ANDERSON EDWARD T Director, 10% Owner | Purchase | +2,708,124 | +68.35%3,123,551 | $1.66 | $4,499,999 | View SEC filing | |
| 2022-06-13 | MERRIFIELD C ANN Director | Purchase | +4,000 | +54.59%11,328 | $5.05 | $20,200 | View SEC filing | |
| 2022-05-17 | MERRIFIELD C ANN Director | Purchase | +3,828 | +109.37%7,328 | $4.83 | $18,486 | View SEC filing | |
| 2022-04-14 | EDELMAN JOSEPH Director, 10% Owner | Purchase | +5,924,170 | +306.30%7,858,285 | $4.22 | $24,999,997 | View SEC filing | |
| 2022-04-14 | NORTH BRIDGE VENTURE PARTNERS V-B LP 10% Owner | Purchase | +2,369,667 | +69.30%1,318,133 | $4.22 | $9,999,995 | View SEC filing | |
| 2022-04-14 | ANDERSON EDWARD T Director, 10% Owner | Purchase | +2,488,150 | +84.51%1,436,616 | $4.22 | $10,499,993 | View SEC filing | |
| 2022-04-13 | Waksal Harlan Executive Chair | Purchase | +236,966 | +100.00%236,966 | $4.22 | $999,997 | View SEC filing | |
| 2021-06-22 | MERRIFIELD C ANN Director | Purchase | +3,500 | +100.00%3,500 | $8.97 | $31,395 | View SEC filing | |
| 2020-12-17 | snyderman nancy lynn MD Director | Purchase | +1,025 | +100.00%1,025 | $9.72 | $9,963 | View SEC filing | |
| 2020-05-29 | EDELMAN JOSEPH Director, 10% Owner | Purchase | +625,000 | +47.74%1,934,115 | $16.00 | $10,000,000 | View SEC filing | |
| 2020-05-15 | Soleus Private Equity Fund I, L.P. 10% Owner | Mixed | +138,091 | -67.32%155,000 | $16.00 | $2,750,544 | View SEC filing | |
| 2020-05-06 | NORTH BRIDGE VENTURE PARTNERS V-B LP 10% Owner | Mixed | +225,817 | -22.68%1,031,246 | $16.00 | $4,386,928 | View SEC filing | |
| 2020-05-06 | ANDERSON EDWARD T Director, 10% Owner | Mixed | +225,817 | -17.75%553,123 | $16.00 | $4,386,928 | View SEC filing | |
| 2020-05-06 | MCGUIRE TERRANCE 10% Owner | Mixed | +52,826 | -99.28%7,274 | $16.00 | $1,154,784 | View SEC filing |
1-23 of 23